OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.
Published in:
BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2872-2
By:
- Coulter, Don W.;
- McGuire, Timothy R.;
- Sharp, John G.;
- McIntyre, Erin M.;
- Yuxiang Dong;
- Xiaofang Wang;
- Gray, Shawn;
- Alexander, Gracey R.;
- Chatuverdi, Nagendra K.;
- Joshi, Shantaram S.;
- Xiaoyu Chen
Publication type:
Article
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo.
Published in:
Cancers, 2023, v. 15, n. 8, p. 2239, doi. 10.3390/cancers15082239
By:
- Rohrer, Kyle A.;
- Song, Heyu;
- Akbar, Anum;
- Chen, Yingling;
- Pramanik, Suravi;
- Wilder, Phillip J.;
- McIntyre, Erin M.;
- Chaturvedi, Nagendra K.;
- Bhakat, Kishor K.;
- Rizzino, Angie;
- Coulter, Don W.;
- Ray, Sutapa
Publication type:
Article
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Published in:
2021
By:
- Kling, Matthew J.;
- Griggs, Connor N.;
- McIntyre, Erin M.;
- Alexander, Gracey;
- Ray, Sutapa;
- Challagundla, Kishore B.;
- Joshi, Shantaram S.;
- Coulter, Don W.;
- Chaturvedi, Nagendra K.
Publication type:
journal article
Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus.
Published in:
2019
By:
- McGuire, Timothy R.;
- Coulter, Don W.;
- Bai, Dachang;
- Sughroue, Jason A.;
- Li, Jerry;
- Yang, Zunhua;
- Qiao, Zhen;
- Liu, Yan;
- Murry, Daryl J.;
- Chhonker, Yashpal S.;
- McIntyre, Erin M.;
- Alexander, Gracey;
- Sharp, John G.;
- Li, Rongshi
Publication type:
journal article
Suppression of STAT3 NH<sub>2</sub>‐terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de‐repression by microRNA‐21.
Published in:
Molecular Carcinogenesis, 2018, v. 57, n. 4, p. 536, doi. 10.1002/mc.22778
By:
- Ray, Sutapa;
- Coulter, Don W.;
- Gray, Shawn D.;
- Sughroue, Jason A.;
- Roychoudhury, Shrabasti;
- McIntyre, Erin M.;
- Chaturvedi, Nagendra K.;
- Bhakat, Kishor K.;
- Joshi, Shantaram S.;
- McGuire, Timothy R.;
- Sharp, John G.
Publication type:
Article
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02944-w
By:
- Coulter, Don W.;
- Chhonker, Yashpal S.;
- Kumar, Devendra;
- Kesherwani, Varun;
- Aldhafiri, Wafaa N.;
- McIntyre, Erin M.;
- Alexander, Gracey;
- Ray, Sutapa;
- Joshi, Shantaram S.;
- Li, Rongshi;
- Murry, Daryl J.;
- Chaturvedi, Nagendra K.
Publication type:
Article
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02530-y
By:
- Kling, Matthew J.;
- Kesherwani, Varun;
- Mishra, Nitish K.;
- Alexander, Gracey;
- McIntyre, Erin M.;
- Ray, Sutapa;
- Challagundla, Kishore B.;
- Joshi, Shantaram S.;
- Coulter, Don W.;
- Chaturvedi, Nagendra K.
Publication type:
Article

Found: 7

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.

STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo.

Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.

Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus.

Suppression of STAT3 NH<sub>2</sub>‐terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de‐repression by microRNA‐21.

Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.